FIELD: organic synthesis. SUBSTANCE: invention provides novel derivative of succinic acid containing photodimerizable cross-linking group and represented by any of formulas 1-3 or its salt: R1-A-H (1), R1-B-OH (2), R2-C-H (3), where R1 denotes group of formula 4: (4), in which R3 and R4 are hydrogen atoms; R2 denotes group of formula 5: (5), in which R3 and R4 are defined above and R5 is low alkyl group; fragment A-H expresses intramolecular residue of amino- and hydroxy-containing compound represented by any of formulas 6-9: -O-(CH2)n-NH2 (6), wherein n is integer from 3 to 18, -(O-CH2CH2)m-NH2 (7), wherein m is integer from 2 to 10, -O-CHR6CH(COOR7)-NH2 (8), wherein R6 is hydrogen and R7 is lower alkyl, and -O-(CH2)l-NHCO-CHR8-NH2 (9), wherein l is integer from 2 to 18 and R8 is side chain of omega-amino acid, hydrogen, or lower alkyl; fragment B-OH expresses amino acid residue of general formula 10: -NH-(CH2)k-COOH (10), wherein k is integer from 1 to 18; and fragment C-H expresses amino acid residue of general formula 11 or 12: -CO-(CH2)k-NH2 (11), wherein k corresponds to above definition, and -(COCHR9NH)i-H (12), wherein i is integer from 1 to 6 and R9 is hydrogen atom. Compounds can be used as medicine-destination material possessing biocompatibility, bioabsorption, and other useful properties. EFFECT: extended choice of compounds suitable for medicinal applications. 26 cl, 61 ex
Authors
Dates
2001-06-20—Published
1995-11-16—Filed